Ph.D. from IIT(BHU) Varanasi, Post-Doctoral Fellow from the University of Texas, Health Science Centre, San Antonio, USA.
Assistant Professor
Pharmaceutical Chemistry
Design, development, and biological profiling of therapeutic modalities for the management of Alzheimer's disease, and Fragile X syndrome. Microglia-Neuron communication, spine abnormality in Fragile X syndrome. Development of gene editing tool viz; CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) molecules and Blood Brain Barrier active polymer for the delivery of CRISPR
Dr. Devendra Kumar is an Assistant Professor in the Department of Pharmacy. Dr. Kumar did his Ph.D. in Pharmaceutical Sciences from Indian Institute of Technology (Banaras Hindu University) and completed his Postdoctoral research from University of Texas, USA (2019-2021). His research interest includes Design, Devolvement and Biological screening of small molecules, Metal complexes, Peptides for the management of Alzheimer's disease, Fragile X Syndrome and Tuberculosis. Dr. Kumar worked on the Alzheimer's disease and developed CNS active small molecules as Acetylcholine, Butyl choline, Beta-secretase 1, Matrix Metalloprotein-2 and 9 inhibitors and NMDA receptor antagonist.
Along with the Drug discovery, He is also working on the Pathophysiology of Fragile X Syndrome. His work on the Fragile X Syndrome includes identification of spine abnormality and role of Microglia. Study of Microglia-Neuron communication in genetically modified animals is his thrust area. He is also working on the gene editing tools using CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology and development of Blood Brain Barrier penetrating Polymers as delivery vehicle for CRISPR molecules.
Pharmaceutical Chemistry, Pharmaceutical Analysis.
Orcid ID: Click here
Google Scholar: Click here
